Partnering

Zihipp is actively seeking licensing and partnering opportunities to advance our pipeline of products. To learn more about our partnering opportunities please contact our business development team at partnering@zihipp.com

Our partnerships

Zihipp entered into an exclusive license with Imperial College London in February 2019 under which it has exclusive rights to certain clinical and pre-clinical GLP-1 and PYY analogue programmes developed at the College, and an associated portfolio of patents and pending applications

Zihipp also has an exclusive option to further related programmes and the associated data and intellectual property arising in the Department of Metabolic Medicine at Imperial College London